Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Ashland (NYSE:ASH) has long anchored its investment thesis on consistent operating cash flow generation, high free cash flow conversion routinely exceeding 90%, and disciplined balance sheet capital allocation. Even in an elevated interest rate environment where borrowing costs penalize balance sheet expansion, strategically increasing leverage remains a prudent move when capital is directed into high-barrier, […]
Ashland Inc. (NYSE:ASH) has long anchored its investment thesis on dependable operating cash flow generation, high free cash flow conversion, and disciplined balance sheet capital allocation. Much like how peers in the broader specialty materials sector deploy targeted capital into mission-critical niches, similar to how Air Products is quietly cornering high-margin chip fab supply chains, […]
Patented technology combines sustainability and performance, supporting next-generation formulations Ashland agrimer™ eco-disperse OD polymeric dispersant Continuing to scale its Transformed Vegetable Oils (TVO™) technology platform, Ashland Inc. (NYSE: ASH), today announced the global launch of agrimer™ eco-disperse OD TVO™ polymeric dispersant, a patented, nature-based dispersant developed for non-aqueous crop protection formulations. WILMINGTON, Del., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Contin
Ashland (ASH) has put a new US$1b share repurchase plan on the table, doubling its prior authorization as management leans into cost savings and portfolio pruning to support margins and free cash flow. Recent trading has been soft, with Ashland’s share price down 5.24% over the past 30 days. However, the year-to-date share price return of 16.57% and 1-year total shareholder return of 38.46% point to momentum building around the cost savings and buyback story. Compare Ashland’s buyback and...
Wilmington, Del., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) will host an Innovation Day webcast on September 17, 2026. The event will begin promptly at 9:00 am ET and conclude by 11:00 am ET. Ashland leadership will provide an updated overview of the company’s innovative Technology Platforms, highlighting their commercial progress and scalability. Registration is required, and participants are encouraged to join early. Registration can be accessed from the following link: https
Wilmington, Del., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) will host a live Innovation Day webcast for analysts and investors from Wilmington, Delaware on September 17, 2026. The event will provide an updated view of Ashland’s Technology Platforms, including their commercial progress and scalability. Registration is required and can be accessed from the following link: innovationday26.ashland.comParticipants will hear from Ashland executives and senior technology leaders as the
Commercialization follows strong interest from pharmaceutical developers worldwide Ashland permexa™ sodium caprate Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium caprate to support the scalable development and commercialization of oral peptide, biologic and low-permeability drug products, including rapidly expanding GLP-1 agonists and related therapeutic pipelines. WILMINGTON, Del., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), is a
WILMINGTON, Del., Aug. 07, 2026 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.42 cents per share on the company's common stock. The dividend will be payable on September 15, 2026, to stockholders of record at the close of business on September 1, 2026. As of July 31, 2026, there were 45,805,711 shares of Ashland common stock outstanding. About Ashland Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients com
What Ashland’s latest quarter tells you about the business Ashland (ASH) reported fiscal third quarter results that combined higher sales and positive net income with lower adjusted earnings guidance. The update, along with reaffirmed full year revenue targets, gives investors fresh context for the stock. See our latest analysis for Ashland. The earnings guidance reset and fresh governance steps, including the new Capital Allocation Advisory Committee, seem to have sharpened attention on...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.